These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 17639094

  • 1. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation.
    Sanchis J, Bosch X, Bodí V, Bellera N, Núñez J, Benito B, Ordóñez J, Consuegra L, Heras M, Llècer A.
    Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094
    [Abstract] [Full Text] [Related]

  • 2. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E, Jernberg T, Johanson P, Venge P, Dellborg M, Wallentin L, Lindahl B, ASSENT-2 and ASSENT-PLUS Study Groups.
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [Abstract] [Full Text] [Related]

  • 3. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [Abstract] [Full Text] [Related]

  • 4. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD, Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators.
    Circulation; 2004 Nov 16; 110(20):3206-12. PubMed ID: 15533869
    [Abstract] [Full Text] [Related]

  • 5. Randomized comparison between clinical evaluation plus N-terminal pro-B-type natriuretic peptide versus exercise testing for decision making in acute chest pain of uncertain origin.
    Sanchis J, Bosch X, Bodí V, Núñez J, Doltra A, Heras M, Mainar L, Santas E, Bragulat E, García-Alvarez A, Carratalá A, Llácer A.
    Am Heart J; 2010 Feb 16; 159(2):176-82. PubMed ID: 20152214
    [Abstract] [Full Text] [Related]

  • 6. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.
    Indian Heart J; 2008 Feb 16; 60(6):536-42. PubMed ID: 19276492
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):357-64. PubMed ID: 19608034
    [Abstract] [Full Text] [Related]

  • 8. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657
    [Abstract] [Full Text] [Related]

  • 9. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 25; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 10. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score.
    Sanchis J, Bodí V, Núñez J, Bertomeu-González V, Gómez C, Bosch MJ, Consuegra L, Bosch X, Chorro FJ, Llàcer A.
    J Am Coll Cardiol; 2005 Aug 02; 46(3):443-9. PubMed ID: 16053956
    [Abstract] [Full Text] [Related]

  • 11. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.
    Am J Med; 2011 Aug 02; 124(8):731-9. PubMed ID: 21787902
    [Abstract] [Full Text] [Related]

  • 12. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.
    Bazzino O, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J, PACS group of investigators.
    Eur Heart J; 2004 May 02; 25(10):859-66. PubMed ID: 15140534
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ, Haeck JD, Kuijt WJ, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, van Straalen JP, Fischer J, Piek JJ, Tijssen JG, de Winter RJ.
    Am J Cardiol; 2010 Apr 15; 105(8):1047-52. PubMed ID: 20381651
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.
    Am J Cardiol; 2009 Jan 01; 103(1):22-8. PubMed ID: 19101224
    [Abstract] [Full Text] [Related]

  • 15. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM, Sease KL, Robey JL, Shofer FS, Hollander JE.
    Ann Emerg Med; 2007 Feb 01; 49(2):153-63. PubMed ID: 17084941
    [Abstract] [Full Text] [Related]

  • 16. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
    Narayan H, Dhillon OS, Quinn PA, Struck J, Squire IB, Davies JE, Ng LL.
    Clin Sci (Lond); 2011 Jul 01; 121(2):79-89. PubMed ID: 21309746
    [Abstract] [Full Text] [Related]

  • 17. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.
    Eur Heart J; 2009 May 01; 30(9):1057-65. PubMed ID: 19168526
    [Abstract] [Full Text] [Related]

  • 18. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.
    Kwan G, Isakson SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1186-92. PubMed ID: 17367663
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Int J Cardiol; 2009 Apr 03; 133(2):173-8. PubMed ID: 18281115
    [Abstract] [Full Text] [Related]

  • 20. N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.
    van der Zee PM, Cornel JH, Bholasingh R, Fischer JC, van Straalen JP, De Winter RJ.
    Am J Med; 2011 Oct 03; 124(10):961-9. PubMed ID: 21962317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.